Two Cases of Angioimmunoblastic T-Cell Lymphoma with Concomitant Positive Serology for Acute Epstein-Barr Virus Infection

Davide Facchinelli; Angela Polino; Francesco Dima; Alice Parisi; Achille Ambrosetti; Dino Veneri

doi:10.4081/hr.2017.7088

Hematology Reports is published by MDPI from Volume 14 Issue 1 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with PAGEPress.

Case Report

27 September 2017

Two Cases of Angioimmunoblastic T-Cell Lymphoma with Concomitant Positive Serology for Acute Epstein-Barr Virus Infection

and

Section of Hematology, Department of Medicine, Policlinico GB Rossi, University of Verona and Azienda Ospedaliera Universitaria Integrata Verona, 37128 Verona, Italy

Laboratory of Clinical Biochemistry, Department of Life and Reproduction Sciences, University of Verona and Azienda Ospedaliera Universitaria Integrata Verona, 37128 Verona, Italy

Department of Pathology and Diagnostics, University of Verona and Azienda Ospedaliera Universitaria Integrata Verona, 37128 Verona, Italy

Author to whom correspondence should be addressed.

Hematol. Rep.2017, 9(3), 7088;https://doi.org/10.4081/hr.2017.7088

Version Notes

Order Reprints

Abstract

Angioimmunoblastic T-cell lymphoma (AITL) is a rare type of peripheral T-cell lymphoma. Epstein-Barr virus (EBV) is known to be associated with pathogenesis and histological progression of AITL and the onset of the disease often mimics an infectious process. Here we describe two cases of patients with serology for acute EBV infection at the onset of AITL.

Keywords:

angioimmunoblastic T-cell lymphoma; Epstein Barr virus; serology for acute infection

Article Metrics

Citations

Article Access Statistics

Journal Statistics

Multiple requests from the same IP address are counted as one view.

Safety and Efficacy of Ibrutinib in a Patient with Severe Renal Impairment